Pain location's diagnostic value is split into three failures—anatomical multiplexing, central amplification, and person-dependent displacement—not one gradient
Synopsis
The paper argues that patient-reported pain location is sometimes diagnostically decisive and sometimes nearly uninformative because it contains three epistemically distinct failures—anatomical multiplexing as a non-identifiable inverse problem, delocalized amplification (clinically central sensitization or nociplastic pain) as a change of generative model, and referred and atypical displacement hypothesized as a systematic, person-dependent shift—which are one Bayesian inference problem failing at the likelihood, the model class, and the group-conditional prior, with a fourth node at the report itself; on this basis the author finds that the published "high-utility" accuracy band leans on overstated specificity, so the gradient is real but flatter than drawn, and attributes the finding th
Figure 1: Figure 1. Two ways to specify the same finger. Naming requires a conversion from a position in the world to a position on your own body map, and the crossed, interlaced posture breaks that conversion — so the named finger comes back wrong. Touch delivers the body-map position directly, with no conversion to break, and the same finger is identified correctly. Nothing about the hand changes between the two attempts; only the route to it does. Errors are near-eliminated by blindfolding and touching the target finger (Van Riper, 1935), and the impairment survives with the eyes closed (Hong et al., 2012), so the reversal contributes independently of visual–proprioceptive conflict. [Analogy / pedagogical — the routing account drawn; no data are plotted.]
arXivInterpretation
The diagnostic utility of pain location is not one gradient but three independent failure modes: anatomical multiplexing (many structures share one location, a non-identifiable inverse problem), delocalized amplification (clinically central sensitization or nociplastic pain, where a centrally driven pain-behaviour pattern replaces the peripheral generator, a change of generative model), and referred and atypical displacement (location hypothesized to shift in a systematic, person-dependent way, a group-conditional bias). Against the prevailing explanation that treats the difference in diagnostic utility as set by anatomical complexity, the paper separates the three as epistemically distinct failures, each with its own mathematics, its own optimal instrument, and its own public-health consequence. The paper is a conceptual and formal organization; the formal development is in a companion paper, and this paper states what each model shows and what follows clinically. The displacement item's direct evidence is explicitly marked by the author as still open.
The three failures can be unified as one Bayesian inference problem failing at different nodes: the likelihood, the model class, and the group-conditional prior, with a fourth node at the report itself. This unification recasts diagnostic utility, previously treated as a single continuous quantity, as multiple separately locatable and separately addressable failure nodes. This is a theoretical organization and model-level argument; the paper offers what each model shows and the clinical corollaries rather than new empirical data.
Re-examination finds that the published "high-utility" accuracy band leans on overstated specificity (Lipton et al., 2003; Bruyninckx et al., 2008; Devillé et al., 2000), so the gradient is real but flatter than drawn. The judgment that the gradient is flatter rests on re-examining existing specificity estimates rather than on a new cohort. The basis is a re-examination of the cited published studies; the paper reports no new sample size or effect size.
The well-evidenced finding that better detection alone does not improve outcomes when treatment uptake lags is about the care pathway, not perception; the three-way split makes this distinction visible while a single utility number hides it. It separates the gap between detection and treatment uptake from the perception-and-diagnosis problem and assigns it to the care pathway, shifting where intervention should aim. The author describes the finding as well evidenced, but the paper gives no specific study, sample, or effect size.
Perspective
The paper addresses clinical pain assessment and care-pathway design: it states what each model shows and what follows clinically, and on that basis sets out the study that would test the one prediction still open. It applies to assessment workflows that use patient-reported pain location as a diagnostic input, especially where the question is how much weight location should carry and why improved detection need not translate into improved outcomes. For a reader, it offers an organizing framework in which failure nodes can be located separately, not a set of directly applicable diagnostic rules.
The direct evidence for displacement is marked by the author as still open, so the systematic, person-dependent shift is currently a hypothesis rather than a conclusion. The paper reports no new sample size, effect size, or specific study design, so a reader wanting to gauge how much flatter the gradient is must return to the cited Lipton et al. (2003), Bruyninckx et al. (2008), and Devillé et al. (2000). In addition, this reading is at summary scope and does not include figures or formal details, so the specific mathematical form of each model and the operationalization of the prediction still to be tested require the original paper and its companion.